Academic publisher John Wiley's Q2 revenue beats on research segment growth

Reuters
2025/12/04
Academic publisher John Wiley's <a href="https://laohu8.com/S/QTWO">Q2</a> revenue beats on research segment growth

Overview

  • John Wiley Q2 revenue beats analyst expectations despite a slight year-over-year decline

  • Adjusted EPS for Q2 surpasses estimates, reflecting strong operational performance

  • Research segment growth driven by global demand and AI initiatives

Outlook

  • Wiley reaffirms fiscal 2026 Adjusted EBITDA margin, EPS, and Free Cash Flow outlook

  • Revenue guidance narrowed to low-single digit growth due to Learning challenges

  • Research and AI momentum expected to remain strong in fiscal 2026

Result Drivers

  • RESEARCH GROWTH - Strong global demand for research publishing and AI projects drove 6% revenue increase in Research segment

  • LEARNING DECLINE - Learning segment revenue fell 11% due to market-related softness and inventory issues

  • COST MANAGEMENT - Reduced corporate expenses by 18% due to restructuring and expense management

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q2 Revenue

Beat

$422 mln

$416.40 mln (1 Analyst)

Q2 Adjusted EPS

Beat

$1.10

$0.97 (1 Analyst)

Q2 EPS

$0.84

Analyst Coverage

  • The one available analyst rating on the shares is "buy"

  • The average consensus recommendation for the consumer publishing peer group is "buy"

  • Wall Street's median 12-month price target for John Wiley & Sons Inc is $60.00, about 58.4% above its December 3 closing price of $37.89

  • The stock recently traded at 9 times the next 12-month earnings vs. a P/E of 10 three months ago

Press Release: ID:nBw6WSxLra

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10